Of possible interest

KEI requests that DHHS Inspector General investigate failure to disclose federal funding in Spinraza patents.

KEI objects to the U.S. Army grant of an exclusive license to Sanofi on U.S. Army-owned patents on a Zika Virus vaccine.

Research and testimony on transparency legislation.

Request to the NIH and U.S. Army to use government royalty free or march-in rights on the prostate cancer drug Xtandi.

Proposal for a WTO Agreement on the Supply of Public Goods.

Innovation inducement prizes as an alternative to IPR monopolies to reward successful innovation.

Now is a good time to donate money to KEI.

KEI timelines, on a variety of topics.

Poll

Governments can ration access to cancer drugs, or break patent monopolies. Why is rationing so popular?:

KEI Report on the IGWG, in Spanish

To facilitate Latin American governments and civil society effective participation in the WHO IGWG process and their better understanding of some of the proposals, KEI has prepared a report in Spanish.

To access an electronic copy of the report, visit: http://www.keionline.org/index.php?option=com_content&task=view&id=49

Blogging the May 30, 2007 Brownbag Lunch: Discussion on New U.S. Trade Policy and Access to Medicine

Thursday, 31 May 2007

On May 30, KEI hosted a brown bag lunch discussion on guidelines for the new U.S. trade policy recently released by the Congressional Ways and Means Committee and the Bush Administration.  The event began with brief statements by panelists Fabiana Jorge of MFJ International, Rob Weissman of Essential Action, James Love of Knowledge Ecology International, and Stephanie Burgos of Oxfam, followed by a wider discussion.

Other Brown Bag Lunches at CPTech


 

May 30, 2007, "The New US Trade Agenda and Access to Medicines"

March 16, 2007,  Robin Hanson on “Why Grants Won Over Prizes in Science.”

March 15, 2007. Sakiko Fukuda-Parr presents on "The Gene Revolution: GM Crops and Unequal Development."

Views on the 60th World Health Assembly IGWG resolution

On 23 May 2007, the 60th World Health Assembly, the World Health Organization’s highest governing body, adopted resolution WHA60.30 on Public health, innovation and intellectual property. This resolution bolstered the work program of WHO’s Intergovernmental Working Group on Public health, innovation and intellectual property (IGWG/PHI). This is the key operative section of the resolution, and the reactions by several key persons.

May 30, 2007: The New US Trade Agenda and Access to Medicines

Tuesday, 29 May 2007
Date:  Wednesday, May 30th, 2007
Time:  12:30-2:00pm
Venue:  1621 Connecticut Avenue Suite 500, Washington, DC 20009

Knowledge Ecology International will host a brown bag lunch and panel discussion on the generic drug/intellectual property provisions in the guidelines for a new US trade policy recently released by the Congressional Ways and Means Committee and the Bush Administration.
The new trade document is available here:

Peter Pitts doesn't like the KSR decision, or prizes

Peter Pitts doesn't like the KSR decision, and he also doesn’t like prizes. His recent Spectator article says:

DISTURBINGLY, SOME FOLKS ARE now advocating a “prize” system where there are no drug patents. Instead, the government would pay a drug maker a lump sum for its innovation, and then the new drug would immediately be placed in the public domain.

The Gotham Prize

The Gotham Prize for cancer research tests the use of prizes to encourage more openness for cancer research. According to their web site:

KEI Statement on WHA/IGWG resolution

Statement by Thiru Balasubramaniam on behalf of KEI, regarding the WHO IGWG resolution:

“The 60th World Health Assembly is taking another important step to change the way the WHO and Member States deal with innovation and access.

KEI Statement on IPR/Health aspects of bipartisan "New Trade Policy"

KEI statement on bipartisan trade agreement
14 May 2007

FMI: James Love james.love@keionline.org, +1.202.361.3040

On May 10, 2007, Speaker Nancy Pelosi and Ways and Means Chair Charles Rangel announced a "new bipartisan " trade package. KEI has reviewed the details of the elements of section III of the agreement, concerning "patents, IPR and access to medicine."

KEI Statement on USTR 301 list reference to Thailand

Monday, 30 April 2007

"The sanctioning of countries for using legitimate and important flexibilities in the TRIPS agreement brings shame to all U.S. citizens who are increasingly seen in Thailand and elsewhere as bullies and hypocrites." 

KEI Statement on USTR 301 list reference to Thailand

Knowledge Ecology International - KEI Statement on USTR 301 list reference to Thailand
KEI Statement on USTR 301 list reference to Thailand

Notes from March 16th 2007 U.S. Capitol Briefing on Thailand’s Compulsory Licenses


On Friday, March 16, KEI organized a briefing in the U.S. Capitol on Thailand’s recent compulsory licenses on three drugs; two for HIV/AIDS (Merck’s efavirenz (Stocrin) and Abbott’s lopinavir + ritonavir (Kaletra)) and one for heart disease (Sanofi’s clopidogrel (Plavix)).  The briefing was sponsored by Senator Sherrod Brown and Congressman Tom Allen.  Rep. Allen’s legislative assistant Todd Stein moderated a panel that included James Love of KEI, Robert Weissman of Essential Action, Dr.

March 16, 2007: Robin Hanson on “Why Grants Won Over Prizes in Science”

Professor Robin Hanson is an economist, teaching at George Mason University.  Before becoming an economist, he worked as a physicist for NASA. On March 16 at KEI, Hanson presented his research on the history of grants and prizes as funding sources for scientific research.  The presentation was based on Hanson’s 1998 working paper, “Patterns of Patronage: Why Grants Won Over Prizes in Science.” (paper, presentation ).

March 8, 2007 Geneva Q&A Session on Thai White Paper

Knowledge Ecology International: Q&A Session on Thai White Paper (Facts and Evidences on the 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand)

Geneva, Switzerland
8 March 2007

Thiru Balasubramaniam 

 

Syndicate content